Skip to main content

Callida Genomics, Michele Delsanter

Premium

Callida Genomics, the microarray subsidiary of Hyseq Pharmaceuticals, has non-exclusively licensed its portfolio of microarray patents to Agilent Technologies for commercial use. Under the agreement, Callida will pay Agilent both up-front fees and any potential royalties.

“This agreement secures access to an important set of patents derived from Radoje Drmanac, currently CSO at Callida, who conducted pioneering work in the early development of microarrays,” Barney Saunders, vice president and general manager of Agilent’s Bioresearch Solutions, said in a statement.

Drmanac has been listed as the inventor on 16 US patents since 1991, the majority of which cover Callida’s Sequencing by Hybridization microarray technology.

“This agreement fits nicely with our licensing strategy for non-universal probes, further validating the strength of our patent portfolio and providing us with future royalty revenue opportunities,” stated George Rathmann, interim president, chairman, and CEO of Callida Genomics.

Michele Delsanter, DE Unterschleissheim, and Michael Galuszka of N rnberg, Germany, have been awarded German patent number DE0010048375A1, “Multifunctional and multiparametric biochip arrangement.” The patent provides a biochip with a sensor unit for measuring the components of body fluids or cell cultures, especially for measuring the components of capillary, venous, or arterial blood. The biochip has a micropump, a controller chip, and a transmitting and receiving unit, and the sensor unit consists of at least one sensor element as well as a reference system for continuous matching with the sensor element. Furthermore, a modular arrangement for measuring the components of body fluids or cell cultures as well as for regulating an organism is provided. This consists of a number of single elements put together according to requirements. The modular arrangement carries a biochip, at least one controlling system for electronic control, rechargeable batteries, a transmitter and receiver device, at least one unit consisting of a storage container, and a micropump for releasing substances.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.